Clinical Significance of CD69 Expression In Chronic Lymphocytic Leukemia
2010 Del Poeta, G; Del Principe, M I; Bulian, P; Simotti, C; Buccisano, F; Luciano, F; Zucchetto, A; Ottaviani, L; Maurillo, L; Sarlo, C; Biagi, A; Gianni, L; Perrotti, A P; Venditti, A; De Fabritiis, P; Gattei, V; Amadori, S
Analysis of parameters influencing the positive selection of peripheral blood progenitor cells in patients with hematological malignancies and solid tumors
1998 Bruno, A; Adorno, G; Del Poeta, G; Venditti, A; Ballatore, G; Zinno, F; Lanti, A; Buccisano, F; Tamburini, A; Caravita, T; Santinelli, S; Maurillo, L; Aronica, G; Masi, M; Isacchi, G; Amadori, S
Consolidation with rituximab improves outcome in high risk B-cell chronic lymphocytic leukemia (B-CLL)
2007 Del Poeta, G; Del Principe, M I; Maurillo, L; Buccisano, F; Niscola, F; Catalano, G; Venditti, A; Gattei, V; Perrotti, A P; De Fabritiis, F; Amadori, S
Normal Fish Cytogenetics and 13q Deletions Unveil Marked Biological and Clinical Heterogeneity In Chronic Lymphocytic Leukemia
2010 Del Poeta, G; Del Principe, M I; Rossi, F M; Coletta, A; Buccisano, F; Simotti, C; Cox, M C; Luciano, F; Zucchetto, A; Maurillo, L; Biagi, A; Niscola, P; Consalvo M, A Irno; Perrotti, A P; Venditti, A; De Fabritiis, P; Gattei, V; Amadori, S
Monitoring of minimal residual disease after autologous stem cell transplantation in adult AML patients
2003 Maurillo, L; Tamburini, A; Buccisano, F; Del Principe, Mi; Venditti, A; Del Poeta, G; De Fabritiis, P; Amadori, S
Multidrug resistance proteins overexpression worsen the favorable clinical impact of an elevated spontaneous apoptosis in acute myeloid leukemia (AML)
2006 Del Poeta, G; Del Principe, Mi; Buccisano, F; Venditti, A; Maurillo, L; Ammatuna, E; Bruno, A; Neri, B; Sarlo, C; Lo Coco, F; De Fabritiis, P; Amadori, S
C-kit receptor tyrosine kinase and mitochondrial apoptotic proteins predict outcome in acute myeloid leukemia (AML)
2002 Del Poeta, G; Del Principe, Mi; Venditti, A; Maurillo, L; Tamburini, A; Buccisano, F; Cox, Mc; Mazzone, C; Marini, R; Bruno, A; Suppo, G; Amadori, S
Dose-intensive, Ara-C/mitoxantrone-based chemotherapy followed by hematopoietic stem cell transplantation for adult acute lymphoblastic leukemia
1998 Buccisano, F; Del Poeta, G; Venditti, A; Tamburini, A; Maurillo, L; Cudillo, L; Morino, L; Postorino, M; Masi, M; Amadori, S
LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) TREATMENT IN ACUTE LEUKAEMIA (AL) PATIENTS WITH SEVERE THROMBOCYTOPENIA AND CONCOMITANT VENOUS OR ARTERIAL THROMBOSIS
2008 Cedrone, M; Chierichini, A; Borza, P Anticoli; Fenu, S; Bongarzoni, V; Anaclerico, B; Ronci, B; Venditti, A; Venditti, D; Maurillo, L; De Fabriitis, P; Annino, L
T-cell-depleted Hematopoietic Stem Cell Transplantation (HSCT) from one haplotype mismatched family donors in patients with high-risk hematologic malignancies
2001 Dentamaro, T; Rainaldi, A; Cudillo, L; Picardi, A; Postorino, M; De Laurenzi, F; Masi, M; Buccisano, F; Maurillo, L; Cupelli, L; Adorno, G; Amadori, S
HIGH CD54 ADHESION MOLECULE EXPRESSION PREDICTS A SHORT PROGRESSION FREE SURVIVAL IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
2008 Del Principe, M I; Bulian, P; Maurillo, L; Buccisano, F; Gianni, L; Siniscalchi, A; Luciano, F; Zucchetto, A; Degan, M; Venditti, A; De Fabritiis, F; Gattei, V; Amadori, S; Del Poeta, G
High CD49d protein expression predicts short overall survival and early progression in chronic lymphocytic leukemia patients
2007 Gattei, V; Bulian, P; Del-Principe, M I; Zucchetto, A; Maurillo, L; Buccisano, F; Bomben, R; Dal-Bo, M; Luciano, F; Rossi, Fm; Degan, M; Amadori, S; Del-Poeta, G
High-dose ARAc/mitoxantrone followed by stem cell transplantation for the treatment of poor-risk lymphoid malignancies
1998 Buccisano, F; Del Poeta, G; Venditti, A; Tamburini, A; Cantonetti, M; Cudillo, L; Aronica, G; Cordero, V; Morino, L; Maurillo, L; Masi, M; Amadori, S
CD49D PROTEIN EXPRESSION REFINES THE PROGNOSTIC IMPACT OF THE TUMOR LOAD MARKERS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2008 Del Poeta, G; Del Principe, M I; Bulian, P; Maurillo, L; Buccisano, F; Gianni, L; Luciano, F; Zucchetto, A; Degan, M; Dal-Bo, M; Siniscalchi, A; Venditti, A; De Fabritiis, P; Gattei, V; Amadori, S
Consolidation and maintenance immunotherapy with rituximab improve progression free survival within ZAP-70 positive chronic lymphocytic leukemia (CLL)
2006 Del Poeta, G; Del Principe, M I; Maurillo, L; Buccisano, F; Venditti, A; Marini, R; Suppo, G; Zucchetto, A; Luciano, F; Cantonetti, M; Gattei, Va; De Fabritiis, P; Amadori, S
Targeting and Depletion of Acute Myeloid Leukemia Blasts By MEN1112, a Novel Humanized Defucosylated Monoclonal Antibodies with Specificity for Bst1/CD157 Antigen
2014 Venditti, A; Buccisano, F; Maurillo, L; Del Principe, Mi; Coppola, A; Palomba, P; Aureli, A; Arriga, R; Bellarosa, D; Bressan, A; Manzini, S; Simonelli, C; Binaschi, M; Amadori, S; Sconocchia, G
Fulminant B hepatitis in a hepatitis B surface antigen-negative patient after rituximab therapy for B-CLL
2005 Niscola, P; Del Giudice, Mi; Maurillo, L; Solmone, M; Capobianchi, Mr; Carletti, F; Piccioni, D; Venditti, A; Amadori, S; Del Poeta, G
HIGH CD54 CELL SURFACE EXPRESSION ON B CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA IS AN INDEPENDENT PREDICTOR OF POOR OUTCOME
2008 Bulian, P; Del Principe, M I; Zucchetto, A; Maurillo, L; Bomben, R; Buccisano, F; Dal Bo, M; Luciano, F; Rossi, F M; Venditti, A; Degan, M; Amadori, S; Gattei, V; Del Poeta, G
5-AZACYTIDINE FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA: RESULTS IN 45 PATIENTS FROM THE ITALIAN PATIENT NAMED PROGRAM
2008 Musto, P; Maurillo, L; Spagnoli, A; Genuardi, M; Lunghi, M; Di Renzo, N; Mele, G; Levis, A; D'Arco, A; Gozzini, A; Petrini, M; Mianulli, M; Sanpaolo, G; Santagostino, A; Pietrantuono, G; D'Auria, E; Ferrero, D; Gaidano, G; Ferrara, E; Santini, V; Leone, G; Bosi, A; Venditti, A
High CD69 protein expression predicts a poor prognosis in B-cell chronic lymphocytic leukemia (B-CLL)
2007 Del Poeta, G; Del Principe, M I; Luciano, F; Maurillo, L; Buccisano, F; Catalano, G; Gianni, L; Coletta, A; Zucchetto, A; Niscola, P; Venditti, A; De Fabritiis, P; Gattei, V; Amadori, S
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Clinical Significance of CD69 Expression In Chronic Lymphocytic Leukemia | 2010 | Del Poeta, G; Del Principe, M I; Bulian, P; Simotti, C; Buccisano, F; Luciano, F; Zucchetto, A; Ottaviani, L; Maurillo, L; Sarlo, C; Biagi, A; Gianni, L; Perrotti, A P; Venditti, A; De Fabritiis, P; Gattei, V; Amadori, S | |
| Analysis of parameters influencing the positive selection of peripheral blood progenitor cells in patients with hematological malignancies and solid tumors | 1998 | Bruno, A; Adorno, G; Del Poeta, G; Venditti, A; Ballatore, G; Zinno, F; Lanti, A; Buccisano, F; Tamburini, A; Caravita, T; Santinelli, S; Maurillo, L; Aronica, G; Masi, M; Isacchi, G; Amadori, S | |
| Consolidation with rituximab improves outcome in high risk B-cell chronic lymphocytic leukemia (B-CLL) | 2007 | Del Poeta, G; Del Principe, M I; Maurillo, L; Buccisano, F; Niscola, F; Catalano, G; Venditti, A; Gattei, V; Perrotti, A P; De Fabritiis, F; Amadori, S | |
| Normal Fish Cytogenetics and 13q Deletions Unveil Marked Biological and Clinical Heterogeneity In Chronic Lymphocytic Leukemia | 2010 | Del Poeta, G; Del Principe, M I; Rossi, F M; Coletta, A; Buccisano, F; Simotti, C; Cox, M C; Luciano, F; Zucchetto, A; Maurillo, L; Biagi, A; Niscola, P; Consalvo M, A Irno; Perrotti, A P; Venditti, A; De Fabritiis, P; Gattei, V; Amadori, S | |
| Monitoring of minimal residual disease after autologous stem cell transplantation in adult AML patients | 2003 | Maurillo, L; Tamburini, A; Buccisano, F; Del Principe, Mi; Venditti, A; Del Poeta, G; De Fabritiis, P; Amadori, S | |
| Multidrug resistance proteins overexpression worsen the favorable clinical impact of an elevated spontaneous apoptosis in acute myeloid leukemia (AML) | 2006 | Del Poeta, G; Del Principe, Mi; Buccisano, F; Venditti, A; Maurillo, L; Ammatuna, E; Bruno, A; Neri, B; Sarlo, C; Lo Coco, F; De Fabritiis, P; Amadori, S | |
| C-kit receptor tyrosine kinase and mitochondrial apoptotic proteins predict outcome in acute myeloid leukemia (AML) | 2002 | Del Poeta, G; Del Principe, Mi; Venditti, A; Maurillo, L; Tamburini, A; Buccisano, F; Cox, Mc; Mazzone, C; Marini, R; Bruno, A; Suppo, G; Amadori, S | |
| Dose-intensive, Ara-C/mitoxantrone-based chemotherapy followed by hematopoietic stem cell transplantation for adult acute lymphoblastic leukemia | 1998 | Buccisano, F; Del Poeta, G; Venditti, A; Tamburini, A; Maurillo, L; Cudillo, L; Morino, L; Postorino, M; Masi, M; Amadori, S | |
| LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) TREATMENT IN ACUTE LEUKAEMIA (AL) PATIENTS WITH SEVERE THROMBOCYTOPENIA AND CONCOMITANT VENOUS OR ARTERIAL THROMBOSIS | 2008 | Cedrone, M; Chierichini, A; Borza, P Anticoli; Fenu, S; Bongarzoni, V; Anaclerico, B; Ronci, B; Venditti, A; Venditti, D; Maurillo, L; De Fabriitis, P; Annino, L | |
| T-cell-depleted Hematopoietic Stem Cell Transplantation (HSCT) from one haplotype mismatched family donors in patients with high-risk hematologic malignancies | 2001 | Dentamaro, T; Rainaldi, A; Cudillo, L; Picardi, A; Postorino, M; De Laurenzi, F; Masi, M; Buccisano, F; Maurillo, L; Cupelli, L; Adorno, G; Amadori, S | |
| HIGH CD54 ADHESION MOLECULE EXPRESSION PREDICTS A SHORT PROGRESSION FREE SURVIVAL IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA | 2008 | Del Principe, M I; Bulian, P; Maurillo, L; Buccisano, F; Gianni, L; Siniscalchi, A; Luciano, F; Zucchetto, A; Degan, M; Venditti, A; De Fabritiis, F; Gattei, V; Amadori, S; Del Poeta, G | |
| High CD49d protein expression predicts short overall survival and early progression in chronic lymphocytic leukemia patients | 2007 | Gattei, V; Bulian, P; Del-Principe, M I; Zucchetto, A; Maurillo, L; Buccisano, F; Bomben, R; Dal-Bo, M; Luciano, F; Rossi, Fm; Degan, M; Amadori, S; Del-Poeta, G | |
| High-dose ARAc/mitoxantrone followed by stem cell transplantation for the treatment of poor-risk lymphoid malignancies | 1998 | Buccisano, F; Del Poeta, G; Venditti, A; Tamburini, A; Cantonetti, M; Cudillo, L; Aronica, G; Cordero, V; Morino, L; Maurillo, L; Masi, M; Amadori, S | |
| CD49D PROTEIN EXPRESSION REFINES THE PROGNOSTIC IMPACT OF THE TUMOR LOAD MARKERS IN CHRONIC LYMPHOCYTIC LEUKEMIA | 2008 | Del Poeta, G; Del Principe, M I; Bulian, P; Maurillo, L; Buccisano, F; Gianni, L; Luciano, F; Zucchetto, A; Degan, M; Dal-Bo, M; Siniscalchi, A; Venditti, A; De Fabritiis, P; Gattei, V; Amadori, S | |
| Consolidation and maintenance immunotherapy with rituximab improve progression free survival within ZAP-70 positive chronic lymphocytic leukemia (CLL) | 2006 | Del Poeta, G; Del Principe, M I; Maurillo, L; Buccisano, F; Venditti, A; Marini, R; Suppo, G; Zucchetto, A; Luciano, F; Cantonetti, M; Gattei, Va; De Fabritiis, P; Amadori, S | |
| Targeting and Depletion of Acute Myeloid Leukemia Blasts By MEN1112, a Novel Humanized Defucosylated Monoclonal Antibodies with Specificity for Bst1/CD157 Antigen | 2014 | Venditti, A; Buccisano, F; Maurillo, L; Del Principe, Mi; Coppola, A; Palomba, P; Aureli, A; Arriga, R; Bellarosa, D; Bressan, A; Manzini, S; Simonelli, C; Binaschi, M; Amadori, S; Sconocchia, G | |
| Fulminant B hepatitis in a hepatitis B surface antigen-negative patient after rituximab therapy for B-CLL | 2005 | Niscola, P; Del Giudice, Mi; Maurillo, L; Solmone, M; Capobianchi, Mr; Carletti, F; Piccioni, D; Venditti, A; Amadori, S; Del Poeta, G | |
| HIGH CD54 CELL SURFACE EXPRESSION ON B CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA IS AN INDEPENDENT PREDICTOR OF POOR OUTCOME | 2008 | Bulian, P; Del Principe, M I; Zucchetto, A; Maurillo, L; Bomben, R; Buccisano, F; Dal Bo, M; Luciano, F; Rossi, F M; Venditti, A; Degan, M; Amadori, S; Gattei, V; Del Poeta, G | |
| 5-AZACYTIDINE FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA: RESULTS IN 45 PATIENTS FROM THE ITALIAN PATIENT NAMED PROGRAM | 2008 | Musto, P; Maurillo, L; Spagnoli, A; Genuardi, M; Lunghi, M; Di Renzo, N; Mele, G; Levis, A; D'Arco, A; Gozzini, A; Petrini, M; Mianulli, M; Sanpaolo, G; Santagostino, A; Pietrantuono, G; D'Auria, E; Ferrero, D; Gaidano, G; Ferrara, E; Santini, V; Leone, G; Bosi, A; Venditti, A | |
| High CD69 protein expression predicts a poor prognosis in B-cell chronic lymphocytic leukemia (B-CLL) | 2007 | Del Poeta, G; Del Principe, M I; Luciano, F; Maurillo, L; Buccisano, F; Catalano, G; Gianni, L; Coletta, A; Zucchetto, A; Niscola, P; Venditti, A; De Fabritiis, P; Gattei, V; Amadori, S |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 01 Pubblicazione su rivista2116
Data di pubblicazione
- 2020 - 2026687
- 2010 - 2019862
- 2000 - 2009452
- 1990 - 1999111
- 1980 - 19892
- 1974 - 19792
Editore
- AMER SOC HEMATOLOGY71
- ELSEVIER17
- SPRINGER17
- ELSEVIER SCIENCE INC14
- WILEY14
- ASSOC RESEARCH VISION OPHTHALMOLOGY INC12
- Minerva medica12
- AMER DIABETES ASSOC11
- CIG MEDIA GROUP, LP10
- LIPPINCOTT WILLIAMS & WILKINS10
Prodotti per rivista
- BLOOD167
- CIRCULATION56
- EUROPEAN HEART JOURNAL54
- ULTRASOUND IN OBSTETRICS & GYNECOLOGY54
- HAEMATOLOGICA53
- ANNALS OF ONCOLOGY51
- ARCHIVIO STORICO ITALIANO35
- MEDITERRANEAN JOURNAL OF CLINICAL PSYCHOLOGY35
- JOURNAL OF CLINICAL ONCOLOGY34
- JOURNAL OF SLEEP RESEARCH27
Prodotti per parola chiave
- sleep19
- melanoma16
- CML10
- Hypertention10
- EEG9
- Hypertension9
- Alexithymia8
- Ipertensione8
- asciminib6
- cancer6
Lingua
- eng1683
- ita198
- fre4
- spa3
- alb1
Accesso al fulltext
- no fulltext2036
- open45
- reserved32
- partially open3